Publications
Return to Publications Listing
C-MAP™ Canadian Drug Benefit Plans Reference Guide
C-MAP™ Canadian Drug Benefit Plans Reference Guide | Frequently Asked Questions | Order Form
C-MAP™ Canadian Drug Benefit Plans Reference Guide 2010 Edition
Download Detailed Outline (51 Kb)
The new features of the 2010 Edition:
- The PMPRB section is extensively enhanced to include highlights of the revised Guidelines to be implemented on January 1, 2010 and latest changes in the PMPRB processes. The section will present more in depth details on the PMPRB rules and regulations.
Ninety per cent of Canadians have some form of drug plan coverage. However, staying up-to-date with the policies and requirements of the various reimbursement schemes is a challenging but necessary requirement for gaining access to the multi-billion dollar Canadian market. This comprehensive reference guide is an essential tool for developing and maintaining a clear understanding of Canada's public and private sector drug plans.
The Canadian Market Access for Pharmaceuticals (C-MAP™) Canadian Drug Benefit Plans Reference Guide 2010 Edition provides detailed information on the formulary listing policies and procedures of the ten provincial prescription drug programs and includes separate chapters on four federal drug programs. There are also detailed overviews of the Provincial Cancer Programs, the Patented Medicine Prices Review Board (PMPRB), the Canadian Agency for Drugs and Technologies in Health (CADTH), Federal/ Provincial/ Territorial Initiatives and the private drug plans in Canada. An extensive section on the Common Drug Review (CDR) provides a comprehensive description of the CDR process including CDR rationale for Canadian Expert Drug Advisory Committee (CEDAC) decisions, time to decision tracking of submissions and CDR submission forms and templates available online. The executive summary provides essential facts on each of the drug plans in convenient tabular format. The Canadian Drug Benefit Plans Reference Guide 2010 Edition is divided into a two-volume set. Volume 1 contains comprehensive details of the various Canadian drug benefit plans. Volume 2 provides formulary submission requirements, deadlines, contacts and checklists for CDR and non-CDR submissions.
This publication includes, but is not restricted to:
- Identification of each provincial drug plan or selected federal program
- Detailed description of each plan
- Identification of the governing acts and regulations
- Drug plan expenditures and use profile
- Formulary descriptions
- Summaries of processes and procedures for listing and approval
- Special authorization processes
- Reimbursement regulations and procedures
- Requirements for manufacturers’ submissions to the Common Drug Reviewand directly to the provincial drug plans including generic products
- A description of the Special Drug Programs for each province
- Reporting structure within each province
- PDCI Market Access online version of C-MAP™ Canadian Drug Benefit Plans Reference Guide
- A glossary of terms
Ongoing updates are provided to existing sections with the latest developments on pricing and reimbursement in the pharmaceutical industry. These updates are provided via email notification.
Subscribers also receive unlimited password-protected access to the online electronic version of C-MAP™ Canadian Drug Benefit Plans Reference Guide 2010 Edition, including all manufacturers’ submission forms and templates, available on the PDCI Market Access website.
The online version of this publication can be accessed by anyone within the subscribing organization.
To order your subscription to the C-MAP™ Canadian Drug Benefit Plans Reference Guide, please use our order form or contact Ara Salazar at (613) 742-8225 or e-mail c-map@pdci.ca or FAX your order to us at (613) 742-7675.
The subscription cost of $4,950.00 CDN, plus $247.50 GST for Canadian orders, includes delivery within Canada. For orders outside of Canada the cost is $4,950.00 US.
Additional copies are available to the same subscriber at a reduced rate of $1500.00 CDN plus $75.00 GST within Canada and $1500.00 US outside of Canada.
Other PDCI Market Access C-MAP™ Services
Login to C-MAP™ Canadian Drug Benefit Plans
Provincial and NIHB Formulary Publishing Dates
